01—Abstract
Summary
Summary of the 10-K filed February 27, 2025. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group Inc. (UNH) presented a solid financial performance for the year ended December 31, 2024, marked by an 8% increase in total revenues to $400.3 billiona.
This growth was primarily driven by strong performance in its Optum segment, particularly Optum Rx and Optum Health, which saw revenue increases of 15% and 11% respectively, alongside a 6% rise in UnitedHealthcare's revenue. Despite a reported net loss of $7.98 billionb on a diluted EPS basis (or $15.51 per share) due to a significant loss on the sale of its Brazil operations and other South American businesses ($8.3 billion), the company demonstrated operational resilience. Key operational highlights include serving a larger member base through UnitedHealthcare's domestic offerings, with a 5% increase in total individuals served.
The company also managed the significant impact of the Change Healthcare cyberattack, incurring $2.2 billionc in direct response costs and an estimated $867 million in business disruption impacts for Optum Insight, while providing over $9 billion in interest-free loans to care providers. Management remains focused on navigating medical cost trends, government funding pressures in Medicare Advantage, and ongoing investments in value-based care models and technology, positioning the company for continued strategic growth.
02—Key points
Key Highlights
- Total revenues increased by 8% to $400.3 billion, driven by strong growth across Optum Rx (+15%) and Optum Health (+11%), and UnitedHealthcare (+6%).
- Despite a reported net loss of $7.98 billion (EPS of $15.51), primarily due to the sale of South American operations, operational earnings remained stable at $32.3 billion.
- UnitedHealthcare saw an increase of 2.1 million individuals served domestically, reflecting growth in commercial offerings, though partially offset by Medicaid redeterminations.
- The company incurred $2.2 billion in direct response costs and $867 million in business disruption impacts from the Change Healthcare cyberattack, while providing $9 billion in interest-free loans to care providers.
- Optum Health served approximately 100 million people, with revenue growth driven by value-based care arrangements.
- The company continues to invest in value-based care models and advanced analytics and technology, crucial for its long-term strategy.
- Dividend per share increased to an annual rate of $8.40, and the company repurchased $9 billion in common stock during the year.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2024, UnitedHealth Group Inc kept $0.04.
- Revenue$400.28B100.0%
- Cost of revenue−$46.69B11.7%
- Gross profit$353.58B88.3%
- Operating costs−$321.30B80.3%
- Operating income$32.29B8.1%
- Interest, other & tax−$17.88B4.5%
- Net income$14.40B3.6%
Where FY2024 revenue went
$400.28B- Other operating costs: $268.28B, 67% of revenue
- SG&A: $53.01B, 13% of revenue
- Net income: $14.40B, 3.6% of revenue
- Cost of revenue: $46.69B, 12% of revenue
- Interest, other & tax: $17.88B, 4.5% of revenue
Kept 3.6% as net incomeNet income $14.40B · 3.6%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2024filed February 27, 2025Financial Statements
FY2024 against FY2023
| Line item | FY2024FY2023 | Change |
|---|---|---|
| Revenue | $400.28B$371.62B | +7.7% |
| Cost of Revenue | $46.69B$38.77B | +20.4% |
| Gross Profit | $353.58B$332.85B | +6.2% |
| SG&A Expenses | $53.01B$54.63B | −3.0% |
| Operating Expenses | $367.99B$339.26B | +8.5% |
| Operating Income | $32.29B$32.36B | −0.2% |
| Interest Expense | $3.91B$3.25B | +20.3% |
| Net Income | $14.40B$22.38B | −35.6% |
| EPS (Basic) | $15.64$24.12 | −35.2% |
| EPS (Diluted) | $15.51$23.86 | −35.0% |
| Shares Outstanding (Basic) | 921.00M928.00M | −0.8% |
| Shares Outstanding (Diluted) | 929.00M938.00M | −1.0% |
05—Questions
Frequently Asked Questions
What was the primary driver of UnitedHealth Group's revenue growth in 2024?
UnitedHealth Group's total revenues grew by 8% to $400.3 billion in 2024. This growth was primarily driven by strong performance in its Optum segment, with Optum Rx revenue increasing by 15% and Optum Health revenue rising by 11%. UnitedHealthcare also contributed with a 6% revenue increase.
How did the Change Healthcare cyberattack impact the company financially and operationally?
The Change Healthcare cyberattack resulted in $2.2 billion in direct response costs for the year ended December 31, 2024, which included providing over $9 billion in interest-free loans to care providers. Optum Insight also experienced an estimated $867 million in business disruption impacts due to lost revenue. The company expects to continue incurring some response costs and business disruption impacts in 2025.
What is the company's outlook on Medicare Advantage funding and medical cost trends?
The company notes ongoing pressure on Medicare Advantage funding due to rate notices from CMS that are below forward medical cost trends. They also observed increased care patterns and higher hospital coding intensity. To mitigate these pressures, UnitedHealth Group may adjust care provider networks, member benefits, and premiums, and selectively choose markets for Medicare Advantage offerings.
How is the company managing its capital and returning value to shareholders?
UnitedHealth Group generated $24.2 billion in cash flows from operations. The company increased its quarterly cash dividend to an annual rate of $8.40 per share and repurchased approximately $9 billion of its common stock during 2024. The company also has a significant portfolio of cash, cash equivalents, and investments totaling $77.1 billion as of year-end 2024, providing substantial financial flexibility.
06—Continue